A multidisciplinary group reviewed the current literature to create an updated consensus statement regarding the use of IL-6 inhibition for inflammatory conditions.
Researchers examined outcomes and adverse events associated with rituximab therapy in older adult patients with ANCA-associated vasculitis.
Case study of a 70-year-old man who presents with vague signs of a rheumatic disease.
Researchers assessed the association between the onset of systemic vasculitis following mRNA COVID-19 vaccination.
A rheumatologist and radiologist share their perspectives on meeting the challenges of diagnosing and treating Takayasu arteritis.
Researchers investigated the prevalence and predictors of subclinical giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica.
Researchers assessed the validity of the EULAR recommendations in the use of pretest probability and color duplex ultrasound for the diagnosis of giant cell arteritis.
The American College of Rheumatology, in conjunction with the Vasculitis Foundation, developed guidelines for rheumatologists for the management of Kawasaki disease.
In light of new treatments and their adverse reactions, study researchers aimed to update the list of drugs associated with ANCA-associated vasculitis.
The American College of Rheumatology/European Alliance of Associations for Rheumatology (ACR/EULAR) developed and validated revised classification criteria for eosinophilic granulomatosis with polyangiitis.